Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Liabilities: 2014-2024

Historic Total Liabilities for AC Immune (ACIU) over the last 11 years, with Dec 2024 value amounting to $135.4 million.

  • AC Immune's Total Liabilities rose 3.64% to $136.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $537.0 million, marking a year-over-year increase of 77.00%. This contributed to the annual value of $135.4 million for FY2024, which is 441.85% up from last year.
  • Per AC Immune's latest filing, its Total Liabilities stood at $135.4 million for FY2024, which was up 441.85% from $25.0 million recorded in FY2023.
  • AC Immune's Total Liabilities' 5-year high stood at $135.4 million during FY2024, with a 5-year trough of $17.6 million in FY2022.
  • For the 3-year period, AC Immune's Total Liabilities averaged around $59.3 million, with its median value being $25.0 million (2023).
  • As far as peak fluctuations go, AC Immune's Total Liabilities tumbled by 45.44% in 2022, and later surged by 441.85% in 2024.
  • Yearly analysis of 5 years shows AC Immune's Total Liabilities stood at $25.7 million in 2020, then increased by 25.31% to $32.2 million in 2021, then plummeted by 45.44% to $17.6 million in 2022, then skyrocketed by 42.08% to $25.0 million in 2023, then soared by 441.85% to $135.4 million in 2024.